Collins, Susan M.

Closed business meeting to consider certain intelligence matters; to be immediately followed by a closed briefing on certain intelligence matters.

Closed hearings to examine certain intelligence matters.

Business meeting to consider S.5038, to prohibit the transfer of the functions of the Office of Special Education and Rehabilitative Services, S.5046, to prohibit the transfer of certain offices and functions of the Department of Education to other Federal agencies, S.2511, to establish a postsecondary student data system, S.3010, to amend the Individuals with Disabilities Education Act to improve provisions relating to dyslexia, S.3589, to amend the Higher Education Act of 1965 to provide students with disabilities and their families with access to critical information needed to select the right college and succeed once enrolled, S.4097, to establish that a State-based education loan program is excluded from certain requirements relating to a preferred lender arrangement, S.4689, to strengthen literacy outcomes for all students, to amend the comprehensive literacy State development grant program, and to ensure Federal accountability and investment in research, teacher preparation, and evidence-based instruction aligned with the science of reading, S.3333, to modify the eligibility requirements and account contribution maximum for pension-linked emergency savings accounts, S.4965, to amend the Railroad Retirement Act of 1974 to establish a Railroad Retirement Board Administrative Account, S.3097, to provide additional protections with respect to health information, and the nominations of Erica Schwartz, of Florida, to be Director of the Centers for Disease Control and Prevention, Sean Kaufman, of Georgia, to be Assistant Secretary for Preparedness and Response, Department of Health and Human Services, and Keith Sonderling, of Florida, to be Secretary of Labor.

Business meeting to consider the nomination of Erica Schwartz, of Florida, to be Director of the Centers for Disease Control and Prevention.

● SPOKEBusiness meeting to consider S.2355, to amend the Public Health Service Act to provide for hospital and insurer price transparency, S.4189, to reduce the price of insulin and provide for patient protections with respect to the cost of insulin, S.4974, to amend the Federal Food, Drug, and Cosmetic Act with respect to food safety, S.5026, to require warning labels on sugar-sweetened foods and beverages, foods and beverages containing high-intensity sweeteners, ultra-processed foods, and foods high in nutrients of concern, such as added sugar, saturated fat, or sodium, to restrict junk food advertising to children, S.1414, to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy, S.3788, to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information, S.3794, to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, S.494, to establish a national plan to coordinate research on epilepsy, S.4110, to revise and extend health workforce programs under title VII of the Public Health Service Act, S.1874, to amend the Public Health Service Act to reauthorize certain nursing workforce development programs, and S.380, to improve obstetric emergency care.

To receive a closed briefing on certain intelligence matters.

● SPOKEHearings to examine a review of the President's supplemental funding request of June 24, 2026.

To receive a closed briefing on certain intelligence matters.

Closed business meeting to consider pending intelligence matters.

Closed business meeting to consider certain intelligence matters.